Impact of Extracorporeal Membrane Oxygenation Bridging Duration on Lung Transplant Outcomes.

ABSTRACT:

Background

We sought to characterize the association between venovenous extracorporeal membrane oxygenation (VV-ECMO) bridging duration and outcomes in patients listed for lung transplantation.

Methods

A retrospective observational study was conducted using the Organ Procurement and Transplantation Network (OPTN) database to identify adults (aged ≥18 years) who were listed for lung transplantation between 2016 and 2020 and were bridged with VV-ECMO. Patients were then stratified into groups, determined by risk inflection points, depending on the amount of time spent on pretransplant ECMO: group 1 (≤5 days), group 2 (6-10 days), group 3 (11-20 days), and group 4 (>20 days). Waiting list survival between groups was analyzed using Fine-Gray competing risk models. Posttransplant

SUBMITTER: Shou BL 

PROVIDER: S-EPMC11284668 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature